| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 11761* | 2021 |
| Parkin, a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25–q27 R Cesari, ES Martin, GA Calin, F Pentimalli, R Bichi, H McAdams, ... Proceedings of the National Academy of Sciences 100 (10), 5956-5961, 2003 | 331 | 2003 |
| High prevalence of RET/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET/PTC3 and the solid … GA Thomas, H Bunnell, HA Cook, ED Williams, A Nerovnya, ... The Journal of Clinical Endocrinology & Metabolism 84 (11), 4232-4238, 1999 | 318 | 1999 |
| Detection of high mobility group I HMGI (Y) protein in the diagnosis of thyroid tumors: HMGI (Y) expression represents a potential diagnostic indicator of carcinoma G Chiappetta, G Tallini, MC De Biasio, G Manfioletti, FJ Martinez-Tello, ... Cancer research 58 (18), 4193-4198, 1998 | 187 | 1998 |
| Transgenic mice overexpressing the wild-type form of the HMGA1 gene develop mixed growth hormone/prolactin cell pituitary adenomas and natural killer cell lymphomas M Fedele, F Pentimalli, G Baldassarre, S Battista, AJP Klein-Szanto, ... Oncogene 24 (21), 3427-3435, 2005 | 162 | 2005 |
| Negative regulation of BRCA1 gene expression by HMGA1 proteins accounts for the reduced BRCA1 protein levels in sporadic breast carcinoma G Baldassarre, S Battista, B Belletti, S Thakur, F Pentimalli, F Trapasso, ... Molecular and cellular biology 23 (7), 2225-2238, 2003 | 162 | 2003 |
| Overexpressed cyclin D3 contributes to retaining the growth inhibitor p27 in the cytoplasm of thyroid tumor cells G Baldassarre, B Belletti, P Bruni, A Boccia, F Trapasso, F Pentimalli, ... Journal of Clinical Investigation 104 (7), 865-874, 1999 | 162 | 1999 |
| Alterations of the tumor suppressor gene Parkin in non-small cell lung cancer MC Picchio, ES Martin, R Cesari, GA Calin, S Yendamuri, T Kuroki, ... Clinical cancer research 10 (8), 2720-2724, 2004 | 149 | 2004 |
| RB1 dual role in proliferation and apoptosis: cell fate control and implications for cancer therapy P Indovina, F Pentimalli, N Casini, I Vocca, A Giordano Oncotarget 6 (20), 17873, 2015 | 146 | 2015 |
| The RET/PTC oncogene is frequently activated in oncocytic thyroid tumors (Hurthle cell adenomas and carcinomas), but not in oncocytic hyperplastic lesions G Chiappetta, P Toti, F Cetta, A Giuliano, F Pentimalli, I Amendola, ... The Journal of Clinical Endocrinology & Metabolism 87 (1), 364-369, 2002 | 132 | 2002 |
| RET activation and clinicopathologic features in poorly differentiated thyroid tumors M Santoro, M Papotti, G Chiappetta, G Garcia-Rostan, M Volante, ... The Journal of Clinical Endocrinology & Metabolism 87 (1), 370-379, 2002 | 128 | 2002 |
| Metabolic syndrome affects breast cancer risk in postmenopausal women: National Cancer Institute of Naples experience I Capasso, E Esposito, F Pentimalli, A Crispo, M Montella, M Grimaldi, ... Cancer biology & therapy 10 (12), 1240-1243, 2010 | 118 | 2010 |
| Haploinsufficiency of the Hmga1 gene causes cardiac hypertrophy and myelo-lymphoproliferative disorders in mice M Fedele, V Fidanza, S Battista, F Pentimalli, AJP Klein-Szanto, R Visone, ... Cancer research 66 (5), 2536-2543, 2006 | 111 | 2006 |
| CXCR4/YY1 inhibition impairs VEGF network and angiogenesis during malignancy F de Nigris, V Crudele, A Giovane, A Casamassimi, A Giordano, ... Proceedings of the National Academy of Sciences 107 (32), 14484-14489, 2010 | 110 | 2010 |
| High mobility group I (Y) proteins bind HIPK2, a serine-threonine kinase protein which inhibits cell growth GM Pierantoni, M Fedele, F Pentimalli, G Benvenuto, R Pero, G Viglietto, ... Oncogene 20 (43), 6132-6141, 2001 | 108 | 2001 |
| RET expression in papillary thyroid cancer from patients irradiated in childhood for benign conditions BJ Collins, G Chiappetta, AB Schneider, M Santoro, F Pentimalli, ... The Journal of Clinical Endocrinology & Metabolism 87 (8), 3941-3946, 2002 | 105 | 2002 |
| High mobility group HMGI (Y) protein expression in human colorectal hyperplastic and neoplastic diseases G Chiappetta, G Manfioletti, F Pentimalli, N Abe, M Di Bonito, MT Vento, ... International journal of cancer 91 (2), 147-151, 2001 | 99 | 2001 |
| HMGA1 protein over-expression is a frequent feature of epithelial ovarian carcinomas V Masciullo, G Baldassarre, F Pentimalli, MT Berlingieri, A Boccia, ... Carcinogenesis 24 (7), 1191-1198, 2003 | 96 | 2003 |
| Mass spectrometry‐based proteomics: The road to lung cancer biomarker discovery P Indovina, E Marcelli, F Pentimalli, P Tanganelli, G Tarro, A Giordano Mass spectrometry reviews 32 (2), 129-142, 2013 | 93 | 2013 |
| HMGA1 Protein Overexpression in Human Breast Carcinomas Correlation with ErbB2 Expression G Chiappetta, G Botti, M Monaco, R Pasquinelli, F Pentimalli, M Di Bonito, ... Clinical cancer research 10 (22), 7637-7644, 2004 | 86 | 2004 |
